Skip to main content
MEDP
NASDAQ Industrial Applications And Services

Chairman Troendle Files to Sell $184.8M in Medpace Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$589.37
Mkt Cap
$16.45B
52W Low
$373
52W High
$677.9
52W Position info
58% above low
Off High info
13% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

MEDP sits 58% above its 52-week low of $373.

Summary

Medpace Chairman August J. Troendle filed a Form 144 to sell 307,959 shares worth about $184.8 million, a significant insider sale that could pressure the stock.


Key Events · Ownership and Investor Activity · MEDP

  • Chairman Plans $184.8M Sale

    August J. Troendle, Chairman of Medpace, filed to sell 307,959 shares worth approximately $184.8 million, representing about 1.1% of outstanding shares.

  • Financial Impact

    The proposed sale would generate roughly $184.8 million in proceeds for Troendle, based on the current market price. The shares were acquired via option exercise in March 2025.

  • Litigation Backdrop

    The sale comes amid ongoing securities class action lawsuits alleging fraud related to the company's book-to-bill ratio, adding potential negative sentiment.

  • Recent Strong Results

    Medpace recently reported strong Q2 2026 results with 17% revenue growth and a record backlog, which may provide some offsetting positive context.


Analysis · MEDP · Industrial Applications And Services

Chairman August J. Troendle intends to sell 307,959 shares worth approximately $184.8 million. This is a significant disposition by the company's chairman, representing about 1.1% of outstanding shares. While the sale is planned under a pre-existing 10b5-1 plan, the size and the filer's role make it a notable event, especially against a backdrop of recent securities litigation and strong Q2 results.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MEDP was trading at $589.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.5B. The 52-week trading range was $373.00 to $677.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEDP - Latest Insights

MEDP
Oct 22, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $653.96
Real-time Price: $605.49 info
Change: -$48.47 (-7%) info
Market Cap: $17.078B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $635.00
Real-time Price: $605.49 info
Change: -$29.51 (-5%) info
Market Cap: $17.078B info
MEDP
Oct 21, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $661.00
Real-time Price: $605.49 info
Change: -$55.51 (-8%) info
Market Cap: $17.078B info
MEDP
Sep 28, 2026, 7:15 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $615.94
Real-time Price: $605.49 info
Change: -$10.45 (-2%) info
Market Cap: $17.078B info
MEDP
Jul 23, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $602.02
Real-time Price: $605.49 info
Change: +$3.47 (+0.58%) info
Market Cap: $17.078B info